JPMorgan Financial Files 424B2 Prospectus for Securities Offering

TL;DR

**JPM's finance arm just filed a prospectus, likely for a new debt or equity offering.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026. This filing, related to File No. 333-270004-01, indicates the offering of securities under an existing registration statement. For investors, this means JPMorgan Chase Financial Co. LLC is actively raising capital, which could impact the parent company's financial structure and future growth initiatives, potentially influencing the stock's long-term value.

Why It Matters

This filing signals JPMorgan Chase Financial Co. LLC is raising capital, which could affect the parent company's balance sheet and strategic investments.

Risk Assessment

Risk Level: low — This is a standard prospectus filing for an offering, not an event that inherently carries high risk, but rather a procedural step in capital raising.

Analyst Insight

Investors should monitor subsequent filings or news from JPMorgan Chase Financial Co. LLC to understand the specific terms (e.g., type of security, amount, interest rate) of this offering and its potential impact on the parent company's financials.

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMorgan Chase & Co. (company) — Parent company of the filer
• March 24, 2026 (date) — Filing date of the 424B2 prospectus
• 333-270004-01 (string) — File number for the offering

FAQ

Key Financial Figures

• $252,000 — al Company LLC Structured Investments $252,000 Callable Contingent Interest Notes Li
• $1,000 — ribed below. Minimum denominations of $1,000 and integral multiples thereof The no
• $27 — roceeds to Issuer Per note $1,000 $27 $973 Total $252,000 $6,804 $2
• $973 — s to Issuer Per note $1,000 $27 $973 Total $252,000 $6,804 $245,196
• $6,804 — 1,000 $27 $973 Total $252,000 $6,804 $245,196 (1) See "Supplemental Use
• $245,196 — 27 $973 Total $252,000 $6,804 $245,196 (1) See "Supplemental Use of Proceeds
• $27.00 — l pay all of the selling commissions of $27.00 per $1,000 principal amount note it rec
• $951.40 — en the terms of the notes were set, was $951.40 per $1,000 principal amount note. See "
• $6.9167 — a Contingent Interest Payment equal to $6.9167 (equivalent to a Contingent Interest Ra
• $228.2500 — tal Contingent Interest Payments 33 $228.2500 32 $221.3333 31 $214.4167 30
• $221.3333 — terest Payments 33 $228.2500 32 $221.3333 31 $214.4167 30 $207.5000 29
• $214.4167 — 33 $228.2500 32 $221.3333 31 $214.4167 30 $207.5000 29 $200.5833 28
• $207.5000 — 32 $221.3333 31 $214.4167 30 $207.5000 29 $200.5833 28 $193.6667 27
• $200.5833 — 31 $214.4167 30 $207.5000 29 $200.5833 28 $193.6667 27 $186.7500 26
• $193.6667 — 30 $207.5000 29 $200.5833 28 $193.6667 27 $186.7500 26 $179.8333 25

Filing Documents

• form424b2.htm (424B2) — 242KB
• exfilingfees.htm (EX-FILING FEES) — 5KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 154KB
• image_007.jpg (GRAPHIC) — 139KB
• image_008.jpg (GRAPHIC) — 6KB
• image_009.jpg (GRAPHIC) — 5KB
• image_010.jpg (GRAPHIC) — 7KB
• image_003.gif (GRAPHIC) — 5KB
• image_004.gif (GRAPHIC) — 2KB
• image_005.gif (GRAPHIC) — 2KB
• 0001918704-26-007933.txt ( ) — 811KB
• exfilingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $252,000 Callable Contingent Interest Notes Linked to the Lesser Performing of the Nasdaq-100 Technology Sector Index SM and the Russell 2000 Index due December 26, 2028 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date for which the closing level of each of the Nasdaq-100 Technology Sector Index SM and the Russell 2000 Index, which we refer to as the Indices, is greater than or equal to 75.00% of its Initial Value, which we refer to as an Interest Barrier. The notes may be redeemed early, in whole but not in part, at our option on any of the Interest Payment Dates (other than the first, second, third, fourth, fifth and final Interest Payment Dates). The earliest date on which the notes may be redeemed early is September 24, 2026. Investors should be willing to accept the risk of losing up to 80.00% of their principal and the risk that no Contingent Interest Payment may be made with respect to some or all Review Dates. Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent Interest Payments. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Payments on the notes are not linked to a basket composed of the Indices. Payments on the notes are linked to the performance of each of the Indices individually, as described below. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660RB78 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS-6 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $27 $973 Total $252,000 $6,804 $245,196 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $27.00 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $951.40 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Indices: The Nasdaq-100 Technology Sector Index SM (Bloomberg ticker: NDXT) and the Russell 2000 Index (Bloomberg ticker: RTY) (each an "Index" and collectively, the "Indices") Contingent Interest Payments: If the notes have not been previously redeemed early and the closing level of each Index on any Review Date is greater than or equal to its Interest Barrier, you will receive on the applicable Interest Payment Date for each $1,000 principal amount note a Contingent Interest Payment equal to $6.9167 (equivalent to a Contingent Interest Rate of 8.30% per annum, payable at a rate of 0.69167% per month). If the closing level of either Index on any Review Date is less than its Inte

View Full Filing

View this 424B2 filing on SEC EDGAR